Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT05396833 |
| Title | Study of M1774 in Combination With DNA Damage Response Inhibitor or Immune Checkpoint Inhibitor (DDRiver Solid Tumors 320) |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | EMD Serono Research & Development Institute, Inc. |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA | ESP | CAN |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| University of Texas M. D. Anderson Cancer Center - Partner | RECRUITING | Houston | Texas | 77030 | United States | Details |
| NEXT Oncology | RECRUITING | San Antonio | Texas | 78229 | United States | Details |
| Princess Margaret Cancer Centre | RECRUITING | Toronto | M5G 2C1 | Canada | Details | |
| Hospital QuironSalud Barcelona - Next Oncology | RECRUITING | Barcelona | 08023 | Spain | Details | |
| Hospital Universitario Quironsalud Madrid - NEXT Oncology | RECRUITING | Madrid | 28223 | Spain | Details |